APO Research
Talk to an analyst

APO RESEARCH · REPORT

Edoxaban Tosilate Tablets and Generic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Edoxaban Tosilate Tablets and Generic Drugs Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchEdoxaban Tosilate Tablets and Generic Drugs Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Edoxaban Tosilate Tablets and Generic Drugs Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Edoxaban Tosilate Tablets and Generic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edoxaban Tosilate Tablets and Generic Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Edoxaban Tosilate Tablets and Generic Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Edoxaban Tosilate Tablets and Generic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Edoxaban Tosilate Tablets and Generic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Edoxaban Tosilate Tablets and Generic Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Edoxaban Tosilate Tablets and Generic Drugs market include Daiichi Sankyo, Lunan Pharmaceutical Group, Menarini Group and Simcere Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Edoxaban Tosilate Tablets and Generic Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Edoxaban Tosilate Tablets and Generic Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Edoxaban Tosilate Tablets and Generic Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Edoxaban Tosilate Tablets and Generic Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Edoxaban Tosilate Tablets and Generic Drugs Segment by Company

Daiichi Sankyo

Lunan Pharmaceutical Group

Menarini Group

Simcere Pharmaceutical

Edoxaban Tosilate Tablets and Generic Drugs Segment by Type

30 mg

60 mg

Other

Edoxaban Tosilate Tablets and Generic Drugs Segment by Application

Hospital

Clinic

Other

Edoxaban Tosilate Tablets and Generic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Edoxaban Tosilate Tablets and Generic Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Edoxaban Tosilate Tablets and Generic Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Edoxaban Tosilate Tablets and Generic Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Edoxaban Tosilate Tablets and Generic Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edoxaban Tosilate Tablets and Generic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edoxaban Tosilate Tablets and Generic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edoxaban Tosilate Tablets and Generic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Edoxaban Tosilate Tablets and Generic Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Edoxaban Tosilate Tablets and Generic Drugs industry.

Chapter 3: Detailed analysis of Edoxaban Tosilate Tablets and Generic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Edoxaban Tosilate Tablets and Generic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Edoxaban Tosilate Tablets and Generic Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Edoxaban Tosilate Tablets and Generic Drugs Industry Trends Table 2. Edoxaban Tosilate Tablets and Generic Drugs Industry Drivers Table 3. Edoxaban Tosilate Tablets and Generic Drugs Industry Opportunities and Challenges Table 4. Edoxaban Tosilate Tablets and Generic Drugs Industry Restraints Table 5. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Share by Company (2021-2026) Table 7. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Edoxaban Tosilate Tablets and Generic Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Edoxaban Tosilate Tablets and Generic Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Edoxaban Tosilate Tablets and Generic Drugs Company, Product Type & Application Table 13. Global Edoxaban Tosilate Tablets and Generic Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Edoxaban Tosilate Tablets and Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 30 mg Table 18. Significant Companies of 60 mg Table 19. Significant Companies of Other Table 20. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type (2021-2026) Table 29. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application (2021-2026) Table 42. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application (2027-2032) Table 43. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2021-2026) Table 46. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region (2027-2032) Table 48. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Region (2021-2026) Table 51. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Region (2027-2032) Table 53. Global Edoxaban Tosilate Tablets and Generic Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Edoxaban Tosilate Tablets and Generic Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026) & (K Units) Table 58. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2021-2026) Table 59. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Country (2027-2032) Table 61. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Market Share by Country (2027-2032) Table 65. Daiichi Sankyo Company Information Table 66. Daiichi Sankyo Business Overview Table 67. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 69. Daiichi Sankyo Recent Development Table 70. Lunan Pharmaceutical Group Company Information Table 71. Lunan Pharmaceutical Group Business Overview Table 72. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 74. Lunan Pharmaceutical Group Recent Development Table 75. Menarini Group Company Information Table 76. Menarini Group Business Overview Table 77. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 79. Menarini Group Recent Development Table 80. Simcere Pharmaceutical Company Information Table 81. Simcere Pharmaceutical Business Overview Table 82. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio Table 84. Simcere Pharmaceutical Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Edoxaban Tosilate Tablets and Generic Drugs Distributors List Table 88. Edoxaban Tosilate Tablets and Generic Drugs Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Edoxaban Tosilate Tablets and Generic Drugs Product Image Figure 2. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Edoxaban Tosilate Tablets and Generic Drugs Sales (2021-2032) & (K Units) Figure 5. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Edoxaban Tosilate Tablets and Generic Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 30 mg Image Figure 10. 60 mg Image Figure 11. Other Image Figure 12. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Edoxaban Tosilate Tablets and Generic Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Edoxaban Tosilate Tablets and Generic Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 30 mg
  • 60 mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Daiichi Sankyo
  • Lunan Pharmaceutical Group
  • Menarini Group
  • Simcere Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Edoxaban Tosilate Tablets and Generic Drugs Market Dynamics
  1. 2.1 Edoxaban Tosilate Tablets and Generic Drugs Industry Trends
  2. 2.2 Edoxaban Tosilate Tablets and Generic Drugs Industry Drivers
  3. 2.3 Edoxaban Tosilate Tablets and Generic Drugs Industry Opportunities and Challenges
  4. 2.4 Edoxaban Tosilate Tablets and Generic Drugs Industry Restraints
3 Edoxaban Tosilate Tablets and Generic Drugs Market by Company
  1. 3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Edoxaban Tosilate Tablets and Generic Drugs Company Ranking (2024-2026)
  6. 3.6 Global Edoxaban Tosilate Tablets and Generic Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Edoxaban Tosilate Tablets and Generic Drugs Company Product Type and Application
  8. 3.8 Global Edoxaban Tosilate Tablets and Generic Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Edoxaban Tosilate Tablets and Generic Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Edoxaban Tosilate Tablets and Generic Drugs Market by Type
  1. 4.1 Edoxaban Tosilate Tablets and Generic Drugs Type Introduction
  2. 4.1.1 30 mg
  3. 4.1.2 60 mg
  4. 4.1.3 Other
  5. 4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Type
  6. 4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Type
  10. 4.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type (2021-2032)
5 Edoxaban Tosilate Tablets and Generic Drugs Market by Application
  1. 5.1 Edoxaban Tosilate Tablets and Generic Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Application
  6. 5.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Application
  10. 5.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application (2021-2032)
6 Edoxaban Tosilate Tablets and Generic Drugs Regional Sales and Value Analysis
  1. 6.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2027-2032)
  5. 6.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Edoxaban Tosilate Tablets and Generic Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Country, 2025 VS 2032
7 Edoxaban Tosilate Tablets and Generic Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2027-2032)
  6. 7.4 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Edoxaban Tosilate Tablets and Generic Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Edoxaban Tosilate Tablets and Generic Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Daiichi Sankyo
  2. 8.1.1 Daiichi Sankyo Company Information
  3. 8.1.2 Daiichi Sankyo Business Overview
  4. 8.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  6. 8.1.5 Daiichi Sankyo Recent Developments
  7. 8.2 Lunan Pharmaceutical Group
  8. 8.2.1 Lunan Pharmaceutical Group Company Information
  9. 8.2.2 Lunan Pharmaceutical Group Business Overview
  10. 8.2.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  12. 8.2.5 Lunan Pharmaceutical Group Recent Developments
  13. 8.3 Menarini Group
  14. 8.3.1 Menarini Group Company Information
  15. 8.3.2 Menarini Group Business Overview
  16. 8.3.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  18. 8.3.5 Menarini Group Recent Developments
  19. 8.4 Simcere Pharmaceutical
  20. 8.4.1 Simcere Pharmaceutical Company Information
  21. 8.4.2 Simcere Pharmaceutical Business Overview
  22. 8.4.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolio
  24. 8.4.5 Simcere Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Edoxaban Tosilate Tablets and Generic Drugs Value Chain Analysis
  2. 9.1.1 Edoxaban Tosilate Tablets and Generic Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Edoxaban Tosilate Tablets and Generic Drugs Sales Mode & Process
  6. 9.2 Edoxaban Tosilate Tablets and Generic Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors
  9. 9.2.3 Edoxaban Tosilate Tablets and Generic Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst